Clinical Evaluation of an Enzyme-linked Immunosorbent Assay (ELISA) for Detecting Pemphigus Antibodies

Nishinihon Journal of Dermatology

Volumn 64, Issue 4, 2002, Pages 464-468

  Kishibe, Mari ^a   Shibaki, Hikaru ^b   Nakane, Hiroshi ^b   Ishida Yamamoto, Akemi ^b   Iizuka, Hajime ^b  

^a Asahikawa Kosei Hospital   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 13844276386     PISSN: 03869784     EISSN: 18804047     Source Type: Journal    
DOI: 10.2336/nishinihonhifu.64.464     Document Type: Article

References (13)

1. Stanley J.R.: Pemphigus; in Dermatology in General Medicine, 5 th ediFitzpatrick TB et al ed), McGraw-Hill Book Co, New York, 1999, 654-666.
2. Stanley J.R.: A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus. J Immunol 136: 1230-1277, 1986.
3. Amagai M., Klaus-Kovtun V., Stanley JR: Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67: 869-877, 1991.
4. Ding X et al : Mucosal and muco-cutaneous(generalized) pemphigusvulgaris show distinct autoantibody profiles. J Invest Dermatol 109: 592-596, 1997.
5. Ishii K. et al: Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linkedi mmunosorbent assay with baculovirus-expressed recombinant desmogleins. J Immunol 159: 2010-2017, 1997.
6. Amagai M. et al: Usefulness of enzyme-linked immunosorbent assay using recombinant desmoglein 1 and 3 for ser-odiagnosis of pemphigus. Br J Dermatol 140: 351-357, 1999.
7. Amagai M. et al: The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 40: 167-170, 1999.
8. Amagai M. et al: Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen(Dsg 3) produced by baculovirus. J Clin Invest 94: 59-67, 1994.
9. Amagai M. et al: Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol 104: 895-901, 1995.
10. Lenz P. et al: Desmoglein 3-ELISA. Arch Dermatol 135: 143-148, 1999.
11. Miyagawa S. et al: Late development of antidesmoglein 1 antibodies in pemphigus vulgaris; correlation with disease progression. Br J Dermatol 141 : 1081-1087, 1999.
12. Scully Cetal: Pemphigus vulgaris: the manifestations and long-term management of 55 patients with oral lesions. Br J Dermatol 140: 84-89, 1999.
13. Harman K.E. et al: Diagnosis of pemphigus by ELISA: a critical evaluation uf two ELISAs for the detection of anybodies to the major pemphigus antigens, desmoglein 1 and 3. Clin Exp Dermatol 25: 236-240, 2000.